IndraLab

Statements


| 1 1

sparser
"No significant binding of MYSM1 to either the PAX3 or the ETS1 promoter sequence around the transcriptional start site (TSS) could be detected in comparison to IgG controls."

reach
"In context with our finding that MYSM1 bound to the c-MET promoter region in close vicinity to PAX3 in melanoma cells, our data indicate that MYSM1 is an epigenetic regulator of melanoma growth and potentially promising new target for tumor therapy."